| abstract |
1-ethyl-7- (2-methyl-6- (1H-1,2,4-triazol-3-yl) pyridin-3-yl) -3,4-dihydropyrazine [2,3-b] pyrazin-2 (1H) -one or a pharmaceutically acceptable salt, clathrate, solvate, stereoisomer, tautomer or isotopologist thereof for use in a method of treating Ewings Sarcoma that overexpresses E-twenty-six (ETS), the method comprising administering a effective amount of 1-ethyl-7- (2-methyl-6- (1H-1,2,4-triazol-3-yl) pyridin-3-yl) -3,4-dihydropyrazine [2,3- b] Pyrazin-2 (1H) -one or a pharmaceutically acceptable salt, clathrate, solvate, stereoisomer, tautomer or isotopologist thereof to a patient who has Ewing's sarcoma that overexpresses STDs. |